Hyperglycemia induced by pasireotide in patients with Cushing’s disease or acromegaly

PURPOSE: Cushing’s disease (CD) and acromegaly are characterized by excessive hormone secretion resulting in comorbidities such as impaired glucose metabolism, diabetes and hypertension. Pasireotide is a new-generation, multireceptor-targeted somatostatin receptor ligand approved for CD (subcutaneou...

Descripción completa

Detalles Bibliográficos
Autor principal: Silverstein, Julie M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4996868/
https://www.ncbi.nlm.nih.gov/pubmed/27405306
http://dx.doi.org/10.1007/s11102-016-0734-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4996868/
https://www.ncbi.nlm.nih.gov/pubmed/27405306
http://dx.doi.org/10.1007/s11102-016-0734-1

Ejemplares similares